Naltrexone in patients with bipolar disorder and alcohol dependence

E. Sherwood Brown, Laura Beard, Lauren Dobbs, A. John Rush

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Bipolar disorder is associated with very high rates of substance abuse. However, few clinical trials are reported in this population. Naltrexone is effective for alcohol dependence, but its safety and efficacy are not established in patients with bipolar disorder and alcohol dependence. A 16-week, open-label, add-on pilot study of naltrexone was conducted in 34 outpatients with bipolar disorder and alcohol dependence. Assessments included the 17-item Hamilton Rating Scale for Depression (HRSD-17), Young Mania Rating Scale (YMRS), Brief Psychiatric Rating Scale (BPRS), and an alcohol craving scale. Alcohol use was quantified. Significant improvement was observed in the HRSD-17 and YMRS, and days of alcohol use and craving decreased significantly. Naltrexone was well tolerated. Controlled trials are warranted.

Original languageEnglish (US)
Pages (from-to)492-495
Number of pages4
JournalDepression and Anxiety
Volume23
Issue number8
DOIs
StatePublished - 2006

Fingerprint

Naltrexone
Bipolar Disorder
Alcoholism
Alcohols
Brief Psychiatric Rating Scale
Substance-Related Disorders
Outpatients
Clinical Trials
Depression
Safety
Population

Keywords

  • Depression
  • Mania
  • Mood disorders
  • Opioid receptor
  • Substance dependence

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Psychology(all)
  • Clinical Psychology

Cite this

Naltrexone in patients with bipolar disorder and alcohol dependence. / Brown, E. Sherwood; Beard, Laura; Dobbs, Lauren; Rush, A. John.

In: Depression and Anxiety, Vol. 23, No. 8, 2006, p. 492-495.

Research output: Contribution to journalArticle

Brown, E. Sherwood ; Beard, Laura ; Dobbs, Lauren ; Rush, A. John. / Naltrexone in patients with bipolar disorder and alcohol dependence. In: Depression and Anxiety. 2006 ; Vol. 23, No. 8. pp. 492-495.
@article{4804ad574f814f9099b5594dc3053a8a,
title = "Naltrexone in patients with bipolar disorder and alcohol dependence",
abstract = "Bipolar disorder is associated with very high rates of substance abuse. However, few clinical trials are reported in this population. Naltrexone is effective for alcohol dependence, but its safety and efficacy are not established in patients with bipolar disorder and alcohol dependence. A 16-week, open-label, add-on pilot study of naltrexone was conducted in 34 outpatients with bipolar disorder and alcohol dependence. Assessments included the 17-item Hamilton Rating Scale for Depression (HRSD-17), Young Mania Rating Scale (YMRS), Brief Psychiatric Rating Scale (BPRS), and an alcohol craving scale. Alcohol use was quantified. Significant improvement was observed in the HRSD-17 and YMRS, and days of alcohol use and craving decreased significantly. Naltrexone was well tolerated. Controlled trials are warranted.",
keywords = "Depression, Mania, Mood disorders, Opioid receptor, Substance dependence",
author = "Brown, {E. Sherwood} and Laura Beard and Lauren Dobbs and Rush, {A. John}",
year = "2006",
doi = "10.1002/da.20213",
language = "English (US)",
volume = "23",
pages = "492--495",
journal = "Depression and Anxiety",
issn = "1091-4269",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Naltrexone in patients with bipolar disorder and alcohol dependence

AU - Brown, E. Sherwood

AU - Beard, Laura

AU - Dobbs, Lauren

AU - Rush, A. John

PY - 2006

Y1 - 2006

N2 - Bipolar disorder is associated with very high rates of substance abuse. However, few clinical trials are reported in this population. Naltrexone is effective for alcohol dependence, but its safety and efficacy are not established in patients with bipolar disorder and alcohol dependence. A 16-week, open-label, add-on pilot study of naltrexone was conducted in 34 outpatients with bipolar disorder and alcohol dependence. Assessments included the 17-item Hamilton Rating Scale for Depression (HRSD-17), Young Mania Rating Scale (YMRS), Brief Psychiatric Rating Scale (BPRS), and an alcohol craving scale. Alcohol use was quantified. Significant improvement was observed in the HRSD-17 and YMRS, and days of alcohol use and craving decreased significantly. Naltrexone was well tolerated. Controlled trials are warranted.

AB - Bipolar disorder is associated with very high rates of substance abuse. However, few clinical trials are reported in this population. Naltrexone is effective for alcohol dependence, but its safety and efficacy are not established in patients with bipolar disorder and alcohol dependence. A 16-week, open-label, add-on pilot study of naltrexone was conducted in 34 outpatients with bipolar disorder and alcohol dependence. Assessments included the 17-item Hamilton Rating Scale for Depression (HRSD-17), Young Mania Rating Scale (YMRS), Brief Psychiatric Rating Scale (BPRS), and an alcohol craving scale. Alcohol use was quantified. Significant improvement was observed in the HRSD-17 and YMRS, and days of alcohol use and craving decreased significantly. Naltrexone was well tolerated. Controlled trials are warranted.

KW - Depression

KW - Mania

KW - Mood disorders

KW - Opioid receptor

KW - Substance dependence

UR - http://www.scopus.com/inward/record.url?scp=33845508873&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845508873&partnerID=8YFLogxK

U2 - 10.1002/da.20213

DO - 10.1002/da.20213

M3 - Article

C2 - 16841344

AN - SCOPUS:33845508873

VL - 23

SP - 492

EP - 495

JO - Depression and Anxiety

JF - Depression and Anxiety

SN - 1091-4269

IS - 8

ER -